Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Market Cap: 2.305B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.305B |
| November 21, 2024 | 2.272B |
| November 20, 2024 | 2.326B |
| November 19, 2024 | 2.312B |
| November 18, 2024 | 2.364B |
| November 15, 2024 | 2.309B |
| November 14, 2024 | 2.662B |
| November 13, 2024 | 2.689B |
| November 12, 2024 | 2.674B |
| November 11, 2024 | 2.731B |
| November 08, 2024 | 2.721B |
| November 07, 2024 | 2.659B |
| November 06, 2024 | 2.653B |
| November 05, 2024 | 2.557B |
| November 04, 2024 | 2.494B |
| November 01, 2024 | 2.423B |
| October 31, 2024 | 2.391B |
| October 30, 2024 | 2.450B |
| October 29, 2024 | 2.484B |
| October 28, 2024 | 2.509B |
| October 25, 2024 | 2.499B |
| October 24, 2024 | 2.478B |
| October 23, 2024 | 2.476B |
| October 22, 2024 | 2.534B |
| October 21, 2024 | 2.547B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.633B |
| October 17, 2024 | 2.591B |
| October 16, 2024 | 2.623B |
| October 15, 2024 | 2.471B |
| October 14, 2024 | 2.407B |
| October 11, 2024 | 2.292B |
| October 10, 2024 | 2.200B |
| October 09, 2024 | 2.218B |
| October 08, 2024 | 2.240B |
| October 07, 2024 | 2.254B |
| October 04, 2024 | 2.340B |
| October 03, 2024 | 2.343B |
| October 02, 2024 | 2.389B |
| October 01, 2024 | 2.384B |
| September 30, 2024 | 2.408B |
| September 27, 2024 | 2.445B |
| September 26, 2024 | 2.439B |
| September 25, 2024 | 2.414B |
| September 24, 2024 | 2.504B |
| September 23, 2024 | 2.486B |
| September 20, 2024 | 2.586B |
| September 19, 2024 | 2.628B |
| September 18, 2024 | 2.583B |
| September 17, 2024 | 2.488B |
| September 16, 2024 | 2.542B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.090B
Minimum
Mar 18 2020
9.401B
Maximum
Jun 25 2021
4.633B
Average
3.952B
Median
Market Cap Benchmarks
| Vaxcyte Inc | 11.04B |
| CEL-SCI Corp | 36.64M |
| AIM ImmunoTech Inc | 13.38M |
| IGC Pharma Inc | 27.57M |
| NovaBay Pharmaceuticals Inc | 3.327M |
Market Cap Related Metrics
| PS Ratio | 11.79 |
| PEG Ratio | -0.0757 |
| Price to Book Value | 6.973 |
| Price | 18.54 |
| Earnings Yield | -25.13% |
| PEGY Ratio | -0.0757 |